Quantinno Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.3M Buy
67,655
+20,646
+44% +$15.6M 0.05% 473
2026
Q2
$29.3M Sell
47,009
-1,242
-3% -$845K 0.04% 565
2026
Q1
$37.3M Buy
48,251
+9,590
+25% +$7.34M 0.06% 383
2025
Q4
$29.8M Buy
38,661
+7,686
+25% +$5.22M 0.06% 378
2025
Q3
$17.4M Buy
30,975
+15,366
+98% +$8.69M 0.05% 443
2025
Q2
$8.19M Buy
15,609
+5,513
+55% +$3.08M 0.04% 617
2025
Q1
$6.4M Buy
10,096
+5,065
+101% +$3.48M 0.04% 545
2024
Q4
$3.58M Sell
5,031
-2,442
-33% -$2.05M 0.04% 612
2024
Q3
$7.86M Buy
7,473
+2,798
+60% +$3.11M 0.1% 196
2024
Q2
$4.91M Buy
4,675
+637
+16% +$618K 0.09% 246
2024
Q1
$3.89M Buy
4,038
+985
+32% +$937K 0.08% 274
2023
Q4
$2.68M Sell
3,053
-213
-7% -$175K 0.09% 271
2023
Q3
$2.69M Buy
3,266
+857
+36% +$674K 0.12% 196
2023
Q2
$1.73M Sell
2,409
-68
-3% -$52.4K 0.1% 261
2023
Q1
$2.04M Buy
2,477
+500
+25% +$377K 0.13% 186
2022
Q4
$1.43M Buy
1,977
+1,372
+227% +$1.01M 0.11% 274
2022
Q3
$417K Sell
605
-24
-4% -$15.1K 0.05% 418
2022
Q2
$372K Sell
629
-15
-2% -$9.8K 0.05% 406
2022
Q1
$450K Buy
+644
New +$407K 0.07% 323

Other funds holding REGN

Quantinno Capital Management's REGN Position: Q3 2026 in Review

Quantinno Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 44% in Q3 2026, buying an estimated $15.6M and bringing the position to 67,655 shares worth $51.3M. The position accounts for 0.05% of the portfolio, ranked #473.

Quantinno Capital Management first reported a position in REGN in Q1 2022 and has held it in 19 quarters since. 1,427 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Quantinno Capital Management held 67,655 shares of Regeneron Pharmaceuticals worth $51.3M as of Q3 2026.
  • Quantinno Capital Management bought 20,646 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $15.6M.
  • Regeneron Pharmaceuticals made up 0.05% of Quantinno Capital Management's portfolio in Q3 2026, its #473 holding.
  • Quantinno Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 19 quarters since.
  • 1,427 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.